Baolingbao BiologyLtd Balance Sheet Health
Financial Health criteria checks 6/6
Baolingbao BiologyLtd has a total shareholder equity of CN¥2.0B and total debt of CN¥363.5M, which brings its debt-to-equity ratio to 17.9%. Its total assets and total liabilities are CN¥2.7B and CN¥642.1M respectively. Baolingbao BiologyLtd's EBIT is CN¥109.4M making its interest coverage ratio 13.6. It has cash and short-term investments of CN¥276.7M.
Key information
17.9%
Debt to equity ratio
CN¥363.52m
Debt
| Interest coverage ratio | 13.6x |
| Cash | CN¥276.72m |
| Equity | CN¥2.03b |
| Total liabilities | CN¥642.07m |
| Total assets | CN¥2.68b |
Recent financial health updates
No updates
Recent updates
Baolingbao BiologyLtd (SZSE:002286) Strong Profits May Be Masking Some Underlying Issues
Nov 05
Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up
Oct 08We Like These Underlying Return On Capital Trends At Baolingbao BiologyLtd (SZSE:002286)
Sep 30Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Business Is Yet to Catch Up With Its Share Price
Jul 03Returns On Capital At Baolingbao BiologyLtd (SZSE:002286) Have Stalled
Jun 07Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders
May 06Financial Position Analysis
Short Term Liabilities: 002286's short term assets (CN¥855.8M) exceed its short term liabilities (CN¥585.5M).
Long Term Liabilities: 002286's short term assets (CN¥855.8M) exceed its long term liabilities (CN¥56.5M).
Debt to Equity History and Analysis
Debt Level: 002286's net debt to equity ratio (4.3%) is considered satisfactory.
Reducing Debt: 002286's debt to equity ratio has reduced from 39.5% to 17.9% over the past 5 years.
Debt Coverage: 002286's debt is well covered by operating cash flow (48.2%).
Interest Coverage: 002286's interest payments on its debt are well covered by EBIT (13.6x coverage).